Home World Omicron variant and vaccines: Moderna and Pfizer are divided on efficacy

Omicron variant and vaccines: Moderna and Pfizer are divided on efficacy

by admin

BERLIN – “In no case, I think, will we be able to count on the same effectiveness that we have experienced in the case of the Delta variant”. The cold shower arrived yesterday morning, from the columns of the Financial Times. The CEO of the drug giant Moderna, Stéphane Bancel, swept away in an interview with the financial newspaper the hope that existing vaccines could be an effective shield against Omicron, the latest coronavirus mutation that has reached Europe.

.

0 comment
0

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy